Use of nepafenac (Nevanac) in combination with intravitreal anti-VEGF agents in the treatment of recalcitrant exudative macular degeneration requiring monthly injections.

Source:http://linkedlifedata.com/resource/pubmed/id/21151329

Download in:

View as

General Info

PMID
21151329